Fresenius Medical Care AG (MEX:FME N) Cyclically Adjusted Revenue per Share: MXN2,945.68 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:FME N Fresenius Medical Care AG MEX:FME N
48 GF Score
Price MXN778.14
GF Value MXN1,670.60
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Cyclically Adjusted Revenue per Share?

Fresenius Medical Care AG MEX:FME N 48 Cyclically Adjusted Revenue per Share is MXN2,945.68 as of Mar. 2026. GuruFocus rates MEX:FME N with a GF Score™ of 48/100 and a GF Value™ of MXN1,670.60 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Fresenius Medical Care AG's adjusted revenue per share for the three months ended in Mar. 2026 was MXN349.323. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN2,945.68 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Fresenius Medical Care AG's average Cyclically Adjusted Revenue Growth Rate was 2.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Fresenius Medical Care AG was 10.00% per year. The lowest was 3.50% per year. And the median was 7.50% per year.

As of today (2026-07-16), Fresenius Medical Care AG's current stock price is MXN778.14. Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was MXN2,945.68. Fresenius Medical Care AG's Cyclically Adjusted PS Ratio of today is 0.26.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius Medical Care AG was 2.41. The lowest was 0.43. And the median was 1.23.


Fresenius Medical Care AG  (MEX:FME N) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Fresenius Medical Care AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=778.14/2945.68
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius Medical Care AG was 2.41. The lowest was 0.43. And the median was 1.23.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Related Terms


Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,513.06 3,192.97 2,760.81 2,484.53 2,747.59

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,422.09 2,285.31 2,509.08 2,747.59 2,945.68

MEX:FME N vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Cyclically Adjusted PS Ratio falls into.


MEX:FME N
48GF Score
Fresenius Medical Care AG MEX:FME N
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fresenius Medical Care AG's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=349.323/131.2583*131.2583
=349.323

Current CPI (Mar. 2026) = 131.2583.

Fresenius Medical Care AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 273.780 100.717 356.801
201609 298.706 101.017 388.130
201612 312.063 101.217 404.684
201703 297.201 101.417 384.651
201706 294.032 102.117 377.940
201709 305.910 102.717 390.911
201712 330.735 102.617 423.046
201803 290.615 102.917 370.644
201806 314.316 104.017 396.632
201809 288.967 104.718 362.206
201812 312.976 104.217 394.183
201903 295.377 104.217 372.017
201906 310.782 105.718 385.865
201909 318.734 106.018 394.618
201912 320.702 105.818 397.805
202003 390.107 105.718 484.354
202006 404.671 106.618 498.195
202009 391.875 105.818 486.090
202012 363.608 105.518 452.309
202103 349.652 107.518 426.857
202106 353.726 108.486 427.977
202109 366.523 109.435 439.615
202112 367.633 110.384 437.157
202203 340.314 113.968 391.943
202206 345.076 115.760 391.274
202209 345.910 118.818 382.128
202212 351.709 119.345 386.818
202303 309.412 122.402 331.798
202306 305.440 123.140 325.576
202309 312.750 124.195 330.538
202312 314.672 123.773 333.702
202403 290.470 125.038 304.920
202406 320.352 125.882 334.035
202409 354.544 126.198 368.761
202412 378.455 127.041 391.018
202503 367.956 127.779 377.974
202506 354.670 128.412 362.532
202509 360.061 129.255 365.641
202512 373.929 129.361 379.414
202603 349.323 131.258 349.323

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN2,945.68 mean?
Fresenius Medical Care AG (MEX:FME N) has a Cyclically Adjusted Revenue per Share of MXN2,945.68 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share too high?
Fresenius Medical Care AG's current Cyclically Adjusted Revenue per Share is MXN2,945.68. Overall, Fresenius Medical Care AG has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share of MXN2,945.68 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Cyclically Adjusted Revenue per Share is MXN2,945.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (MEX:FME N) is currently considered Possible Value Trap. The stock's GF Value™ is MXN1,670.60, compared to a current price of MXN778.14 — trading 53.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN2,945.68. Fresenius Medical Care AG's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Fresenius Medical Care AG (MEX:FME N), the current Cyclically Adjusted Revenue per Share is MXN2,945.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (MEX:FME N) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of MXN778.14 is trading 53.4% below its estimated GF Value™ of MXN1,670.60. GuruFocus considers Fresenius Medical Care AG to be Possible Value Trap.

Key valuation signals for MEX:FME N:

  • Cyclically Adjusted Revenue per Share: MXN2,945.68
  • GF Value™: MXN1,670.60 vs. price of MXN778.14 (53.4% below fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the MEX:FME N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
48GF Score

Get the complete analysis for MEX:FME N

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN778.14
Price
MXN1,670.60
GF Value